Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(02): 289-290
DOI: 10.4103/ijmpo.ijmpo_238_17
Practitioner Section

Hodgkin Lymphoma Presenting as Immune Thrombocytopenia

Mili Jain
Departments of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India
,
Neetu Pandey
Departments of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India
,
Nishant Verma
Departments of Paediatrics, King George’s Medical University, Lucknow, Uttar Pradesh, India
,
Ashutosh Kumar
Departments of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Immune thrombocytopenia (ITP) in lymphoid malignancies has been observed primarily in relation to chronic lymphoproliferative disorders. ITP in Hodgkin lymphoma (HL) is a rare presentation, most often reported at follow-up. We report a case of a 12-year-old female presenting with symptomatic thrombocytopenia at the time of diagnosis of HL. The patient had stage III B bulky disease with HL mixed cellularity subtype on histology. The patient was treated with adriamycin, bleomycin, vinblastine, and dacarbazine regime along with local radiation therapy and is in complete remission at 18 months of follow-up. The treatment of underlying lymphoma in such cases resolves thrombocytopenia.

Keywords

Hodgkin lymphoma - immune thrombocytopenia - thrombocytopenia


Publication History

Article published online:
03 June 2021

© 2019. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Visco C, Rodeghiero F. Immune thrombocytopenia in lymphoproliferative disorders. Hematol Oncol Clin North Am 2009; 23: 1261-74
    CrossrefPubMedGoogle Scholar
  • 2 Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: Pathogenic and clinical diversity. Blood 2009; 113: 6511-21
    CrossrefPubMedGoogle Scholar
  • 3 Jain M, Oberoi G, Kumar R, Kumar A. Erythrovirus B19 induced persistent bicytopenia in a healthy child. Rev Bras Hematol Hemoter 2017; 39: 278-80
    CrossrefPubMedGoogle Scholar
  • 4 Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH. et al. Autoimmunity and susceptibility to Hodgkin lymphoma: A population-based case-control study in Scandinavia. J Natl Cancer Inst 2006; 98: 1321-30
    CrossrefPubMedGoogle Scholar
  • 5 Dimou M, Angelopoulou MK, Pangalis GA, Georgiou G, Kalpadakis C, Pappi V. et al. Autoimmune hemolytic anemia and autoimmune thrombocytopenia at diagnosis and during follow-up of Hodgkin lymphoma. Leuk Lymphoma 2012; 53: 1481-7
    CrossrefPubMedGoogle Scholar
  • 6 Dahlqvist C, Betomvuko P, Verdebout JM, Mineur P. Immune thrombocytopenic purpura at the diagnosis of Hodgkin disease. Acta Clin Belg 2010; 65: 41-3
    CrossrefPubMedGoogle Scholar
  • 7 Ertem M, Uysal Z, Yavuz G, Gözdaşoǧlu S. Immune thrombocytopenia and hemolytic anemia as a presenting manifestation of Hodgkin disease. Pediatr Hematol Oncol 2000; 17: 181-5
    CrossrefPubMedGoogle Scholar
  • 8 Lechner K, Chen YA. Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma. Leuk Lymphoma 2010; 51: 469-74
    CrossrefPubMedGoogle Scholar